, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting

29 October 2019 At: ACC/HO 023/19 Re: Management Discussion and Analysis for the Quarter of 3/2019 To: President The Stock Exchange of Thailand In the third quarter of 2019, there were concern on the

-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021

13486, including relevant licenses 6,336 square meters 3 76 items of machinery and equipment for the manufacturing business, including relevant licenses - This is to improve the financial position and

person under Section 258 3. Date of filing this report to the SEC 24 January 2020 4. The highest price paid by the reporting person or person in the same group 1 for its acquisition of the securities

September 2020. 4. The highest price paid by the reporting person or person in the same group 1 for its acquisition of the securities during the past 90-day period (the first day being the date of action

3. Date of filing this report to the SEC 28 October 2020 4. The highest price paid by the reporting person or person in the same group 1 for its acquisition of the securities during the past 90-day

filing this report to the SEC 30 October 2020. 4. The highest price paid by the reporting person or person in the same group 1 for its acquisition of the securities during the past 90-day period (the first

. 7. Date of filing this report to the SEC 25 November 2020. The highest price paid by the reporting person or person in the same group 1 for its acquisition of the securities during the past 90-day

December 2020. 4. The highest price paid by the reporting person or person in the same group 1 for its acquisition of the securities during the past 90-day period (the first day being the date of action